Over the last 12 months, MediWound insiders reported 6 buys totaling $136K and no sales across SEC Form 4 filings.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | SHAMIR NACHUMD | ▲ Buy | 5,825 | $14 | $82K | +11.7% | — |
| Jun 3, 2026 | SHAMIR NACHUMD | ▲ Buy | 175 | $13.97 | $2K | +0.4% | — |
| Jun 1, 2026 | Fox David MortonD | ▲ Buy | 1,797 | $14 | $25K | +8.8% | — |
| Jun 1, 2026 | Fox David MortonD | ▲ Buy | 10 | $14.23 | $142 | — | — |
| Jun 1, 2026 | Fox David MortonD | ▲ Buy | 1,730 | $14.22 | $25K | +9.2% | — |
| May 29, 2026 | Rubinstein SamuelD | ▲ Buy | 150 | $14.33 | $2K | +5.3% | — |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $MDWD feed.